(Q38819263)

6 September 2017

title

KCa 3.1-a microglial target ready for drug repurposing? (English)

1 reference

6 September 2017

1 reference

Elena Dale

1

1 reference

6 September 2017

Roland G W Staal

series ordinal

2

1 reference

6 September 2017

Claudia Eder

series ordinal

3

1 reference

6 September 2017

Thomas Möller

series ordinal

4

1 reference

6 September 2017

publication date

28 April 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

64

1 reference

6 September 2017

issue

10

1 reference

6 September 2017

page(s)

1733-1741

1 reference

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the A

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

TRAM-34, a putatively selective blocker of intermediate-conductance, calcium-activated potassium channels, inhibits cytochrome P450 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Dose-escalation study of ICA-17043 in patients with sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker se

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Central nervous system myeloid cells as drug targets: current status and translational challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Calcium-activated potassium channel SK1- and IK1-like immunoreactivity in injured human sensory neurones and its regulation by neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Management of painful neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Target validation using chemical probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Drug repositioning for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Ion channels in monocytes and microglia/brain macrophages: promising therapeutic targets for neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Pharmacological properties of Ca2+-activated K+ currents of ramified murine brain macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

KCa3.1/IK1 Channel Regulation by cGMP-Dependent Protein Kinase (PKG) via Reactive Oxygen Species and CaMKII in Microglia: An Immune Modulating Feedback System?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Ion channels and transporters in lymphocyte function and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Ion channels in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

The art of the chemical probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Microglia biology in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Immunotherapy in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Cancer drug discovery by repurposing: teaching new tricks to old dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Glial cell changes in epilepsy: overview of the clinical problem and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

A human intermediate conductance calcium-activated potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

hSK4, a member of a novel subfamily of calcium-activated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

What happened to anti-CD33 therapy for acute myeloid leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

21 January 2018

Physiology of microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

IKCa channels are a critical determinant of the slow AHP in CA1 pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Drug repositioning and repurposing: terminology and definitions in literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Control of hypothalamic-pituitary-adrenal stress axis activity by the intermediate conductance calcium-activated potassium channel, SK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Novel inhibitors of the Gardos channel for the treatment of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

The distribution of small and intermediate conductance calcium-activated potassium channels in the rat sensory nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Metabotropic glutamate receptors as drug targets: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Pain signalling pathways: from cytokines to ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Targeting of microglial KCa3.1 channels by TRAM-34 exacerbates hippocampal neurodegeneration and does not affect ictogenesis and epileptogenesis in chronic temporal lobe epilepsy models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Drug repositioning for orphan diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Ion channel expression in resting and activated microglia of hippocampal slices from juvenile mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

TRAM-34 inhibits nonselective cation channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Non-selective cation channel activity is required for lysophosphatidylcholine-induced monocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Microglial K(+) channel expression in young adult and aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1 Ca(2+)-dependent K(+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Drug Repurposing for the Development of Novel Analgesics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Ion channels on microglia: therapeutic targets for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Effects of imidazole antimycotics on the liver microsomal cytochrome P450 isoforms in rats: comparison of in vitro and ex vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

KCa3.1 modulates neuroblast migration along the rostral migratory stream (RMS) in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

IKCa-channel blockers. Part 2: discovery of cyclohexadienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

4-Phenyl-4H-pyrans as IK(Ca) channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Expression and function of calcium-activated potassium channels in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Therapeutic potential of KCa3.1 blockers: recent advances and promising trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Modulators of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels and their Therapeutic Indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Inhibition of cytochromes P450 by antifungal imidazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

7 January 2021

Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

7 January 2021

Drug repositioning in Alzheimer rsquo s disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

7 January 2021

K+ channels and the microglial respiratory burst

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

7 January 2021

Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22992

7 January 2021

Identifiers

DOI

10.1002/GLIA.22992

1 reference

6 September 2017

1 reference